AAPEP Pharmaceuticals is developing a novel antibiotic to combat antibiotic-resistant bacteria such as MRSA (methicillin-resistant staphylococcus aureus), VREF (vancomycin-resistant enterococcus ...
The presence of these pathogens was highest in the hospital's ICUs, with A baumannii, K pneumoniae, P aeruginosa, and E faecium most significantly associated with ICUs. "These pathogens were found to ...
Purpose. The chemistry, pharmacology, antimicrobial activity, pharmacokinetics, pharmacodynamics, efficacy and safety in humans, and formulary considerations of doripenem are reviewed. Summary ...